Mathews Open Access Journals follow certain ethical standards to make sure high-quality scientific publications, to attain public confidence in scientific findings.
Plagiarism/ Duplicate Submission: Mathews Open Access Journals firmly encourages original manuscripts and must not use the words, figures, or ideas of others without attribution. All sources must be cited at the point they are used, and reuse of wording must be limited and be attributed or quoted in the text. The content should not be submitted/ published elsewhere with other publishing groups. Our quality control teams check for the plagiarism through software to detect the overlapping of content and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.
Data Fabrication and Falsification: If the submitted manuscripts are found to have either fabricated or falsified research work, i.e. methods, experimental results, including the manipulation of images will be immediately rejected.
Conflicts of Interest: Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for coauthors declaring their interests.
Human and Animal Rights: Ethical clearance documents need to be provided if applicable. The work involving animal models and human volunteers need to submit the necessary statements.
In the above publication ethical cases if the violations are found, the editorial office is authorized to take action accordingly.
Published : 20th March 2023
Authors : Deepak Dalal*, Ravi Kant, Reena Badhwar
Citation : Dalal D, et al. (2023). A Review on Analytical Method of Dapagliflozin and Empagliflozin by QBD Approach. Mathews J Pharma Sci. 7(1):17.
Published : 03rd February 2023
Authors : Harish Joshi, Ragini Bundela, Sourabh Jain*, Karunakar Shukla
Citation : Joshi H, et al. (2023). Formulation and Evaluation of Nanoparticles Containing Antiviral Protease Inhibitor. Mathews J Pharma Sci. 7(1):16.
Published : 25th January 2023
Authors : Prashant Upadhyay*, Kalpana, Priya Chaudhary, Sukirti Upadhyay
Citation : Upadhyay P, et al. (2023). A Review on Formulation and Evaluation Approaches for Fast Release Tablet. Mathews J Pharma Sci. 7(1):15.
Published : 06th January 2023
Author : Gudisa Bereda*
Citation : Bereda G. (2023). Definition, Causes, Pathophysiology, and Management of Hypothyroidism. Mathews J Pharma Sci. 7(1):14.
Published : 26th December 2022
Author : Abdul Kader Mohiuddin*
Citation : Mohiuddin AK. (2022). Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya. Mathews J Pharma Sci. 6(1):13.
Published : 21st December 2022
Author : Abdul Kader Mohiuddin*
Citation : Mohiuddin AK. (2022). Adherence to Medication and Treatment Guidelines: Most Important but Mostly Despised. Mathews J Pharma Sci. 6(1):12.